BMRN

BIOMARIN PHARMACEUTICAL INC

Pharmaceutical Preparations · SIC 2834CIK 1048477Held by 10 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:X LINKEDIN EMAIL

10 managers · Q2 2026 13F

13F bookWeight

Viking Global Investors

Andreas HalvorsenPosition history →

1.2%

+7.9%

$435.8M

$35.08B13F book · 2026-06-30

Deerfield Management Company

Deerfield Management CompanyPosition history →

0.80%

+56.5%

$76.3M

$9.59B13F book · 2026-06-30

Torray Funds

TorrayPosition history →

0.60%

(0.6%)

$4.4M

$0.74B13F book · 2026-06-30

Dodge & Cox

Dodge & CoxPosition history →

0.44%

+1.9%

$849.4M

$191.01B13F book · 2026-06-30

Bridgewater Associates

Bridgewater AssociatesPosition history →

0.06%

+32.9%

$15.7M

$24.38B13F book · 2026-06-30

Renaissance Technologies

Renaissance TechnologiesPosition history →

0.04%

(55.9%)

$25.9M

$72.62B13F book · 2026-06-30

Capital Research Global Investors

Capital Research Global InvestorsPosition history →

0.03%

+0.4%

$200.5M

$716.87B13F book · 2026-06-30

Motley Fool Asset Management

Motley Fool Asset ManagementPosition history →

0.01%

(3.9%)

$0.2M

$2.59B13F book · 2026-06-30

WCM Investment Management

WCM Investment ManagementPosition history →

<0.01%

+21.8%

$1.3M

$55.16B13F book · 2026-06-30

Holocene Advisors

Holocene AdvisorsPosition history →

<0.01%

—

$0.7M

$43.69B13F book · 2026-06-30

Weight = position value ÷ the manager's total 13F long-equity value in the same filing — one definition for every row. “1st obs.” marks a position with no earlier stored 13F to compare against — it is not shown as a purchase.